Metformin therapy in patients with chronic kidney disease
- 7 May 2012
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 14 (10), 963-965
- https://doi.org/10.1111/j.1463-1326.2012.01617.x
Abstract
Metformin therapy is limited in patients with chronic kidney disease (CKD) due to the potential risk of lactic acidosis. This open‐label observational study investigated metformin and lactate concentrations in patients with CKD (n = 22; creatinine clearances 15–40 ml/min) and in two dialysed patients. Patients were prescribed a range of metformin doses (250–2000 mg daily) and metformin concentrations were compared with data from healthy subjects (scaled to 1500 mg twice daily). A subset of patients (n = 7) was controlled on low doses of metformin (250 or 500 mg daily). No correlation between metformin and lactate concentrations was observed. Three patients had high lactate concentrations (>2.7 mmol/l) and two had high metformin concentrations (3–5 mg/l), but none had any symptoms of lactic acidosis. Reducing metformin dosage and monitoring metformin concentrations will allow the safe use of metformin in CKD, provided that renal function is stable.Keywords
This publication has 10 references indexed in Scilit:
- Establishment of a Database of Metformin Plasma Concentrations and Erythrocyte Levels in Normal and Emergency SituationsClinical Drug Investigation, 2011
- Metformin: The Safest Hypoglycaemic Agent in Chronic Kidney Disease?Nephron Clinical Practice, 2011
- Clinical Pharmacokinetics of MetforminClinical Pharmacokinetics, 2011
- Limitations of metformin use in patients with kidney disease: are they warranted?Diabetes, Obesity and Metabolism, 2010
- Novel Assay of Metformin Levels in Patients With Type 2 Diabetes and Varying Levels of Renal FunctionDiabetes Care, 2010
- Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin PharmacokineticsCancer Cell, 2007
- Steady-State Pharmacokinetics of a Novel Extended-Release Metformin FormulationClinical Pharmacokinetics, 2005
- Rapid determination of metformin in human plasma using ion-pair HPLCJournal of Pharmaceutical and Biomedical Analysis, 2002
- The relationship between metformin therapy and the fasting plasma lactate in type 2 diabetes: The Fremantle Diabetes StudyBritish Journal of Clinical Pharmacology, 2001
- Metformin kinetics in healthy subjects and in patients with diabetes mellitus.British Journal of Clinical Pharmacology, 1981